Showing results (81-90 of 401) with videos related to
Sort By:
Pageof 41
Cancer Research|May 19, 2006
Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signalingMark A Gerber, Scott M Bahr, David H GutmannThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 23, 2010
Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosityJacquelyn A Brown, Scott M Gianino, David H GutmannMolecular and Cellular Biology|January 2, 2003
T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expressionZhi-yong Huang, YanLi Wu, Nicolé Hedrick, et al.Epilepsia|September 17, 2013
Epilepsy in individuals with neurofibromatosis type 1Adam P Ostendorf, David H Gutmann, Judith L Z WeisenbergStem Cells (Dayton, Ohio)|March 20, 2015
Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent mannerR Hugh F Bender, Kevin M Haigis, David H GutmannCurrent Opinion in Neurology|January 25, 2003
Neurofibromatosis 2Michael E Baser, D Gareth R Evans, David H GutmannDermatology Online Journal|February 12, 2020
Melanoma in individuals with neurofibromatosis type 1: a retrospective studyMay Zhang, Trisha Bhat, David H Gutmann, et al.Familial Cancer|December 20, 2014
Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry InitiativeQian Liu, Nancy Zoellner, David H Gutmann, et al.Annals of Neurology|April 5, 2008
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complexLing-Hui Zeng, Lin Xu, David H Gutmann, et al.Neurology. Genetics|September 29, 2017
Children with 5'-end NF1 gene mutations are more likely to have gliomaCorina Anastasaki, Stephanie M Morris, Feng Gao, et al.Pageof 41